Integral Ad Science Holding Corp. (NASDAQ:IAS) Position Trimmed by Ameriprise Financial Inc.

Ameriprise Financial Inc. trimmed its stake in Integral Ad Science Holding Corp. (NASDAQ:IAS) by 3.1% in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 1,102,299 shares of the company’s stock after selling 35,642 shares during the quarter. Ameriprise Financial Inc.’s holdings in Integral Ad Science were worth $11,508,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other institutional investors have also made changes to their positions in the company. Vanguard Group Inc. lifted its position in Integral Ad Science by 2.3% in the 4th quarter. Vanguard Group Inc. now owns 9,048,546 shares of the company’s stock worth $94,467,000 after buying an additional 205,562 shares in the last quarter. Alyeska Investment Group L.P. acquired a new position in shares of Integral Ad Science in the fourth quarter worth $41,543,000. Dimensional Fund Advisors LP raised its holdings in shares of Integral Ad Science by 18.1% during the fourth quarter. Dimensional Fund Advisors LP now owns 3,789,996 shares of the company’s stock worth $39,567,000 after acquiring an additional 580,323 shares in the last quarter. Ararat Capital Management LP boosted its position in Integral Ad Science by 13.4% during the fourth quarter. Ararat Capital Management LP now owns 2,281,912 shares of the company’s stock valued at $23,823,000 after purchasing an additional 269,346 shares during the last quarter. Finally, Geode Capital Management LLC grew its stake in Integral Ad Science by 0.8% in the fourth quarter. Geode Capital Management LLC now owns 1,848,738 shares of the company’s stock valued at $19,305,000 after purchasing an additional 14,079 shares in the last quarter. 95.78% of the stock is currently owned by institutional investors and hedge funds.

Integral Ad Science Price Performance

Shares of Integral Ad Science stock opened at $8.09 on Monday. The company has a current ratio of 3.71, a quick ratio of 3.71 and a debt-to-equity ratio of 0.07. The firm has a fifty day simple moving average of $7.67 and a 200-day simple moving average of $9.60. The stock has a market capitalization of $1.33 billion, a price-to-earnings ratio of 40.45, a PEG ratio of 1.06 and a beta of 1.55. Integral Ad Science Holding Corp. has a 1-year low of $6.26 and a 1-year high of $13.62.

Integral Ad Science (NASDAQ:IAS) last announced its earnings results on Monday, May 12th. The company reported $0.05 EPS for the quarter, topping the consensus estimate of $0.03 by $0.02. Integral Ad Science had a net margin of 6.39% and a return on equity of 3.47%. The firm had revenue of $134.07 million for the quarter, compared to the consensus estimate of $129.20 million. On average, sell-side analysts expect that Integral Ad Science Holding Corp. will post 0.26 earnings per share for the current year.

Insider Transactions at Integral Ad Science

In related news, CEO Lisa Utzschneider sold 8,547 shares of the business’s stock in a transaction on Monday, April 7th. The shares were sold at an average price of $6.85, for a total transaction of $58,546.95. Following the transaction, the chief executive officer now owns 341,271 shares of the company’s stock, valued at approximately $2,337,706.35. The trade was a 2.44% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is available through this hyperlink. Over the last ninety days, insiders have sold 86,222 shares of company stock worth $636,252. Company insiders own 2.00% of the company’s stock.

Wall Street Analyst Weigh In

A number of equities research analysts have recently weighed in on the company. Morgan Stanley cut their price target on Integral Ad Science from $13.50 to $12.50 and set an “equal weight” rating for the company in a research note on Thursday, April 17th. Barclays raised their price objective on shares of Integral Ad Science from $7.00 to $9.00 and gave the company an “equal weight” rating in a research report on Tuesday, May 13th. Raymond James boosted their target price on shares of Integral Ad Science from $11.00 to $13.00 and gave the stock an “outperform” rating in a research report on Tuesday, May 13th. Scotiabank initiated coverage on shares of Integral Ad Science in a research note on Friday, February 28th. They set a “sector perform” rating and a $12.00 price target on the stock. Finally, Benchmark reaffirmed a “hold” rating on shares of Integral Ad Science in a research note on Friday, February 28th. Six analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to data from MarketBeat.com, Integral Ad Science presently has a consensus rating of “Moderate Buy” and an average target price of $13.55.

Integral Ad Science Company Profile

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Ireland, Germany, Italy, Singapore, Australia, Japan, India, and the Nordics. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.